Leprosy: A glossary

Clinics in Dermatology - Tập 33 - Trang 8-18 - 2015
Marcos Virmond1, Andrzej Grzybowski2,3, Luiza Virmond4
1Division of Rehabilitation, Instituto Lauro de Souza Lima, Rod Cmt Joao R de Barros, Km 226, Bauru-SP, 17034-971, Brazil
2Department of Ophthalmology, Poznan City Hospital, ul., Szwajcarska 361-285 Poznan, Poland
3Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland
4Department of Internal Medicine, School of Medicine, Pontifical Catholic University, Rua Imaculada Conceição 1155, Prado Velho, Curitiba, Parana, 80215-901, Brazil

Tài liệu tham khảo

Browne, 1989, The history of leprosy Robbins, 2009, Ancient skeletal evidence for leprosy in India (2000 B.C.), PLoS ONE, 4, e5669, 10.1371/journal.pone.0005669 World Health Organization Wisssman, 2004, Preventive health care and screening of Latin American immigrants in the United States, J Am Board Fam Pract, 7, 310 Markandeya, 2002, Ninhydrin sweat test in the early detection of leprosy, Int J Lepr, 70, 125 Moet, 2008, Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial, BMJ, 336, 761, 10.1136/bmj.39500.885752.BE Richardus, 2013, The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study), BMC Infect Dis, 13, 456, 10.1186/1471-2334-13-456 Rambukkana, 2002, Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells, Science, 3, 927, 10.1126/science.1067631 Lockwood, 2005, Leprosy: too complex a disease for a simple elimination paradigm, Bull World Health Organ [serial on the Internet], 83, 230 Lockwood, 2014, Hazards of setting targets to eliminate disease: lessons from the leprosy elimination campaign, BMJ, 348, g1136, 10.1136/bmj.g1136 Ustianowski, 2006, Interactions between HIV infection and leprosy: a paradox, Lancet Infect Dis, 6, 350, 10.1016/S1473-3099(06)70493-5 World Health Organization, 2002 International Federation of Anti-Leprosy Associations, 2007, 21 Cole, 2001, Massive gene decay in the leprosy bacillus, Nature, 409, 1007, 10.1038/35059006 van Brakel, 2006, The Participation Scale: measuring a key concept in public health, Disabil Rehabil, 28, 193, 10.1080/09638280500192785 Gupta, 2010, Is phenolic glucolipidic 1 really a specific antigen for leprosy?, Clin Infect Dis, 50, 937, 10.1086/650541 Ridley, 1966, Classification of leprosy according to immunity a five system, Int J Lepr, 34, 255 Nardi, 2012, Limitations in activities of people affected by leprosy after completing multidrug therapy: application of the SALSA scale, Lepr Rev, 83, 172, 10.47276/lr.83.2.172